INS and Hyperglycemia: In 2012, Umpierrez et al. published practice guidelines for managing hyperglycemia in non-critically ill hospitalized patients, recommending the initiation of insulin therapy, such as basal–bolus insulin (BBI), for blood glucose (BG) levels exceeding 140 mg/dL that persist for 24–48 h during GC therapy [13].